<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: licensure announnced by wuxi biologics and gloria pharmaceuticals of the fully human pd-1 antibody, gls-010 , to arcus biosciences	</title>
	<atom:link href="https://www.worldpharmatoday.com/drug-research/licensure-announnced-by-wuxi-biologics-and-gloria-pharmaceuticals-of-the-fully-human-pd-1-antibody-gls-010-to-arcus-biosciences/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com/drug-research/licensure-announnced-by-wuxi-biologics-and-gloria-pharmaceuticals-of-the-fully-human-pd-1-antibody-gls-010-to-arcus-biosciences/</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Thu, 17 Aug 2017 05:10:55 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
